BMJ Open (Apr 2023)

Codesigning a social prescribing pathway to address the social determinant of health concerns of children with cerebral palsy and their families in Australia: a protocol for a mixed-methods formative research study

  • Laurel Mimmo,
  • Karen Zwi,
  • Susan Woolfenden,
  • Simon Paget,
  • Raghu Lingam,
  • Sarah Mcintyre,
  • Hayley Smithers Sheedy,
  • Valsamma Eapen,
  • Tanya Martin,
  • Timothy Scott,
  • Anne Masi,
  • Iva Strnadová,
  • Katarina Ostojic,
  • Betty-Jean Dee-Price,
  • Heather Burnett,
  • Alison Berg,
  • Michele Scarcella,
  • Jack Calderan,
  • Sheikh Azmatullah,
  • Masyitah Mohamed,
  • Mackenzie Woodbury,
  • Alunya Wilkinson,
  • Russell Dale

DOI
https://doi.org/10.1136/bmjopen-2022-066346
Journal volume & issue
Vol. 13, no. 4

Abstract

Read online

Introduction Social determinants of health (SDH) are contributors to health inequities experienced by some children with cerebral palsy and pose barriers to families engaging with complex and fragmented healthcare systems. There is emerging evidence to support ‘social prescribing’ interventions that systematically identify SDH concerns and refer patients to non-medical social care support and services to address their needs. To date, social prescribing has not been trialled specifically for children with neurodevelopmental disabilities, including cerebral palsy, in Australia. This study aims to codesign a social prescribing programme to address SDH concerns of children with cerebral palsy and their families who attend one of the three tertiary paediatric rehabilitation services in New South Wales, Australia.Methods and analysis This is a qualitative multi-site study conducted at the three NSW paediatric hospitals’ rehabilitation departments using a codesign approach. Children aged 12–18 years with cerebral palsy, parents/caregivers of children (aged 0–18 years) with cerebral palsy, and clinicians will be involved in all stages to codesign the social prescribing programme. The study will consist of three components: (1) ‘what we need’, (2) ‘creating the pathways’ and (3) ‘finalising and sign off’. This project is overseen by two advisory groups: one group of young adults with cerebral palsy and one group of parents of young people with cerebral palsy. The study will be guided by the biopsychosocial ecological framework, and analysis will follow Braun and Clark’s thematic approach.Ethics and dissemination The study protocol was approved by the human research ethics committee of the Sydney Children’s Hospitals Network. This codesign study will inform a future pilot study of feasibility and acceptability, then if indicated, a pilot clinical trial of efficacy. We will collaborate with all project stakeholders to disseminate findings and undertake further research to build sustainable and scalable models of care.Trial registration number ACTRN12622001459718.